Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

Nature正文已收录本站
  • Timothy P. Heffernan

    Present address: C4 Therapeutics, Cambridge, Massachusetts, USA

  • Lynda Chin

    Present address: Institute for Health Transformation, The University of Texas System, Austin, Texas, USA

  • These authors contributed equally: Alessandro Carugo, James Tepper, Frederick Scott Robinson, Liren Li

  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Giannicola Genovese, Alessandro Carugo, James Tepper, Frederick Scott Robinson, Liren Li, Maria Svelto, Luigi Nezi, Denise Corti, Rosalba Minelli, Piergiorgio Pettazzoni, Tony Gutschner, Chia-Chin Wu, Sahil Seth, Kadir Caner Akdemir, Samirkumar Amin, Koichi Takahashi, Andrea Viale, Giulio F. Draetta & Lynda Chin

  • Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Alessandro Carugo, Frederick Scott Robinson, Elisabetta Leo, Virginia Giuliani, Jill Garvey, Jianhua Zhang, Timothy P. Heffernan, Giulio F. Draetta & Lynda Chin

  • European Institute of Oncology, Milano, Italy

    Alessandro Carugo

  • Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China

    Liren Li

  • Istituto di Patologia Generale, Universitá Cattolica del Sacro Cuore, Roma, Italy

    Maria Svelto & Alessandro Sgambato

  • Graduate program in Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, Texas, USA

    Samirkumar Amin

  • Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, Maryland, USA

    Marco Dal Molin, Michael G. Goggins & Laura D. Wood

  • Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Haoqiang Ying

  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Lawrence N. Kwong

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Simona Colla & Koichi Takahashi

  • Office of Technology Commercialization, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Papia Ghosh

  • Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Florian Muller

  • Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Prasenjit Dey, Shan Jiang & Ronald A. DePinho

  • Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Chang-Gong Liu

  • ORBIT Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Carlo Toniatti

  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Jason B. Fleming

  • Department of Pathology, Friedrich Alexander University Erlangen-Nuremberg, University Hospital, Erlangen, Germany

    Abbas Agaimy

  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Anirban Maitra & Huamin Wang

  • Sheikh Ahmed Bin Zayed Al Nahyan Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

    Anirban Maitra

  • Comprehensive Cancer Center and Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

    Charles W. M. Roberts